Skip to main content
. 2003 Jan 22;138(2):333–342. doi: 10.1038/sj.bjp.0705046

Figure 7.

Figure 7

Transverse sections of CBCNM preparations exposed to (a) vehicle (BSA); (b) A. rugosus venom (30 μg ml−1); (c) acanmyotoxin-1 (0.1 μM); (d) acanmyotoxin-1 (1 μM); (e) acanmyotoxin-1 (1 μM) in the presence of antivenom (5 units ml−1). Scale bars, 100 μm in all micrographs. Arrowheads indicate prominent vacuoles.